IP Library Assignment 072472/0233
Patent Assignment
Reel/Frame 072472/0233

Amended and Restated Patent Security Agreement

Recorded: 2025-08-18 Pages: 46
Assignor
UROGEN PHARMA LTD.
Executed: 2025-08-15
Assignee
BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties (21)
Treatment of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer with a Thermally Gelling Pharmaceutical Composition Containing Mitomycin
Application: 18/784,354 →
Publication: US 2025/0032409
Immunomodulating Treatments of Body Cavities
Application: 18/180,152 →
Publication: US 2023/0218521
Immunomodulating Treatments of Body Cavities
Application: 19/094,915 →
Publication: US 2025/0221929
Material and Method for Treating Internal Cavities
Application: 19/066,754 →
Publication: US 2025/0195665
Immunomodulating Treatments of Body Cavities
Application: 18/665,612 →
Publication: US 2024/0382420
Material and Method for Treating Internal Cavities
Patent: 9,040,074 →
Application: 13/553,198 →
Publication: US 2013/0046275
Material and Method for Treating Internal Cavities
Application: 14/720,676 →
Publication: US 2015/0366974
Material and Method for Treating Internal Cavities
Patent: 9,950,069 →
Application: 15/366,256 →
Publication: US 2017/0112935
Material and Method for Treating Internal Cavities
Application: 14/054,731 →
Publication: US 2014/0105884
Biocompatible Drug Delivery Apparatus and Methods
Patent: 8,361,490 →
Application: 10/941,942 →
Publication: US 2006/0057208
Phospholipid Drug Analogs
Patent: 9,173,936 →
Application: 13/772,235 →
Publication: US 2013/0267481
Phospholipid Drug Analogs
Patent: 9,180,183 →
Application: 13/772,253 →
Publication: US 2013/0266635
Phospholipid Drug Analogs
Patent: 9,540,407 →
Application: 14/869,677 →
Publication: US 2016/0090395
Slow Release Formulations of Cell Cycle Regulators and Anti-Cancer Agents for Local Treatment of Solid Cancer
Patent: 9,801,854 →
Application: 14/600,354 →
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Patent: 9,066,940 →
Application: 13/147,194 →
Publication: US 2011/0319442
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Patent: 9,107,919 →
Application: 13/775,906 →
Publication: US 2013/0237561
Material and Method for Treating Cancer
Application: 17/546,204 →
Publication: US 2022/0202773
Thermosensitive Bio-Adhesive Hydrogel for Removal of Ureteral and Renal Stones
Application: 17/703,238 →
Publication: US 2022/0304766
A Connectable Catheter
Application: 15/322,044 →
Publication: US 2017/0136222
Material and Method for Treating Internal Cavities
Application: 18/625,862 →
Publication: US 2024/0299550
Material and Method for Treating Cancer
Application: 18/535,108 →
Publication: US 2024/0108603
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 16, 2004
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 015817/0081 →
Assignment of Assignor's Interest Sep 14, 2011
From: LEONI, LORENZO; MAJ, ROBERTO; PATTARINO, FRANCO; VECCHIO, CARLO
To: TELORMEDIX SA
Reel/Frame 026906/0392 →
Assignment of Assignor's Interest Nov 5, 2012
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 029238/0909 →
Assignment of Assignor's Interest Jun 20, 2013
From: MAJ, ROBERTO; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 030655/0891 →
Assignment of Assignor's Interest Nov 3, 2013
From: LEONI, LORENZO; MAJ, ROBERTO; PATTARINO, FRANCO; VECCHIO, CARLO
To: TELORMEDIX SA
Reel/Frame 031533/0541 →
Assignment of Assignor's Interest Jan 9, 2014
From: KONORTY, MARINA; HAKIM, GIL
To: THERACOAT LTD
Reel/Frame 031947/0586 →
Assignment of Assignor's Interest Oct 27, 2015
From: MAJ, ROBERT; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 036895/0721 →
Change of Name Nov 13, 2015
From: THERACOAT LTD
To: UROGEN PHARMA LTD
Reel/Frame 037111/0567 →
Asset Purchase Agreement Nov 13, 2015
From: TELORMEDIX SA
To: THERACOAT LTD.
Reel/Frame 037109/0769 →
Change of Name Nov 24, 2015
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037135/0053 →
Change of Name Jan 19, 2016
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037553/0678 →
Assignment of Assignor's Interest Feb 4, 2016
From: TELORMEDIX, SA
To: UROGEN PHARMA LTD.
Reel/Frame 037668/0353 →
Assignment of Assignor's Interest Jan 8, 2018
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 044556/0637 →
Change of Name Jan 8, 2018
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 045016/0287 →
Change of Name Mar 15, 2021
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 055588/0095 →
Security Interest Apr 8, 2021
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICAV
Reel/Frame 055868/0385 →
Security Interest Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Assignment of Assignor's Interest Apr 7, 2022
From: HIONIDI, YULIA; TSIPORI, OMER; KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 059528/0317 →
Amended and Restated Patent Security Agreement May 19, 2022
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICA V
Reel/Frame 060121/0591 →
Assignment of Assignor's Interest Jan 5, 2023
From: TSIPORI, OMER; SCHOENBERG, MARK
To: UROGEN PHARMA LTD.
Reel/Frame 062278/0061 →
Assignment of Assignor's Interest Jan 5, 2023
From: CLAYMAN, RALPH V.; JIANG, PENGBO
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 062278/0012 →
Assignment of Assignor's Interest Mar 23, 2023
From: HAKIM, GIL; STRAUSS-AYALI, DALIT; FRIEDMAN, ASTAR; KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 063072/0794 →
Patent Security Agreement Aug 18, 2023
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064641/0263 →
Patent Security Agreement Mar 18, 2024
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066805/0346 →
Assignment of Assignor's Interest Feb 23, 2025
From: CREASY, CARETHA L.
To: UROGEN PHARMA LTD.
Reel/Frame 070299/0524 →